Pregnancy in patients with premature ovarian failure

References

• de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil. Steril.18, 440–461 (1967).
   PubMed Web of Science ®Google Scholar
• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet. Gynecol.67, 604–606. (1986).
   PubMed Web of Science ®Google Scholar
• Sherins RJ. Gonadal dysfunction. In: Cancer–Principles and Practice of Oncology. de Vita VT Jr, Hellman S, Rosenberg SA (Eds). JB Lippincott Co., PA, USA 2395–2406 (1993).
   Google Scholar
• Chattopadhyay D, Sen MR, Katiyar P, Pandey LK. Antiovarian antibody in premature ovarian failure. Indian J. Med. Sci.53, 254–258 (1999).
   PubMedGoogle Scholar
• Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet. Gynecol.89, 777–779 (1997).
   PubMed Web of Science ®Google Scholar
• Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum. Reprod. Update12, 573–584 (2006)
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum. Reprod.11, 1620–1626 (1996).
   PubMed Web of Science ®Google Scholar
• Oktay K, Pelin Cil A, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil. Steril.86, 70–80 (2006).
   PubMed Web of Science ®Google Scholar
• Kuwayama M, Vajita G, Kato O, Leibo SP. Highly efficient vitrifiation method for cryopreservation of human oocytes. Reprod. Biomed. Online11, 300–308 (2005).
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet364, 1405–1410 (2004).
   PubMed Web of Science ®Google Scholar
• van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum. Reprod. Update5, 483–492 (1999).
   PubMed Web of Science ®Google Scholar
• Corrigan EC, Raygada MJ, Vanderhoof VH, Nelson LM. A woman with spontaneous premature failure gives birth to a child with fragile X syndrome. Fertil. Steril.84, 1508 (2005).
   PubMedGoogle Scholar
• Hovatta O. Pregnancies in women with Turner’s syndrome. Ann. Med.31, 106–110 (1999).
   PubMed Web of Science ®Google Scholar
• Swapp GH, Johnston AW, Watt JL, Couzin DA, Stephen GS. A fertile women with non-mosaic Turner’s syndrome. Case report and review of the literature. Br. J. Obstet. Gynaecol.96(7), 876–880 (1989).
   PubMedGoogle Scholar
• Sauer MV, Paulson RJ, Ary BA, Lobo RA. Three hundred cycles of oocyte donation at the University of South California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J. Assist. Reprod. Genet.11, 92–96 (1994).
   PubMed Web of Science ®Google Scholar
• Yaron Y, Ochshorn Y, Amit A, Yovel I, Kogosowski A, Lessing J. Patients with Turner’s syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation. Fertil. Steril.65, 1249–1252 (1996).
   PubMed Web of Science ®Google Scholar
• Li TC, Dockery P, Ramsewak SS, Klentzeris L, Lenton EA, Cooke ID. The variation of endometrial response to a standard hormone replacement therapy in women with premature ovarian failure. An ultrasonographic and histological study. Br. J. Obstet. Gynaecol.98(7), 656–561 (1991).
   PubMedGoogle Scholar
• Press F, Shapiro HM, Cowell CA, Oliver GD. Outcome of ovum donation in Turner’s syndrome patients. Fertil. Steril.64, 995–998 (1995).
   PubMed Web of Science ®Google Scholar
• Muñoz EA. The aetiology of POF does not influence the reproductive outcome. Presented at: 21st. Annual Meeting of the European Society for Human Reproduction and Embryology. Copenhagen, Denmark, 19–22 June 2005.
   Google Scholar
• Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner’s syndrome: an analysis of factors affecting the outcome. Hum. Reprod.12, 279–285 (1999).
   Web of Science ®Google Scholar
• Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics101(1), E11 (1998).
   PubMed Web of Science ®Google Scholar
• Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J. Am. Coll. Cardiol.38(6), 1728–1733 (2001).
   PubMed Web of Science ®Google Scholar
• Hawkins MM. Pregnancy outcome and offspring after childhood cancer. Br. Med. J.309, 1034 (1994).
   PubMedGoogle Scholar
• Pados G, Camus M, Van Waesberghe L, Liebaers I, Van Steirteghem A, Devroey P. Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum. Reprod.7, 1111–1117 (1992).
   PubMed Web of Science ®Google Scholar
• Letur-Konirsch H, Guis F, Duymes M, Alnot MO, Fernandez H. Precocious menopause after antimitotic therapy. Is in vitro fertilization with oocyte donation the only appropriated response? Contracept. Fertil. Sex.25, 647–653 (1997).
   PubMedGoogle Scholar
• Busso C, Budak EB, Melo MAB, Simon C, Pellicer A, Remohí J. Oocyte donation in patients with premature ovarian failure after chemotherapy and pelvic irradiation for Hodgkin’s and non Hodgkin’s disease. Presented at: 23rd Annual Meeting of the European Society for Human Reproduction and Embryology. Lyon, France, 1–4 July 2007.
   Google Scholar
• Blumenfeld Z, Halachmi S, Alik Peretz B et al. Premature ovarian failure – the prognostic application of autoimmunity on conception after ovulation induction. Fertil. Steril.59(4), 750–755 (1993).
   PubMed Web of Science ®Google Scholar
• Muñoz EA, Muñoz M, Navarro J, Simon C, Remohí J, Pellicer A. Reproductive outcome of premature ovarian failure. Presented at: 18th Annual Meeting of the European Society for Human Reproduction and Embryology. Vienna, Austria, 30 June – 3 July 2002.
   Google Scholar